Search results for: 'Cancer Diagnostics Market, liquid biopsy'
- Related search terms
- cancer vaccine market
- cancer immunotherapy global market
- Diagnostics-as-a-Service (DaaS) Emerges as a Groundbreaking Business Model, Transforming Automotive Diagnostics
- Cancer market in UAE
- cancer vaccin market
-
30 Oct 2025  |  Global  |  Technology Research
At-Home Diagnostics Innovations and Growth Opportunities
Transition from Smart Home to Smarter Health At Home Fueling Technology Competition
At-home diagnostics is a rapidly growing field constantly exploring new and innovative solutions to address the challenges of diagnosing broad-spectrum disorders. Recent advancements in emerging at-home diagnostics technologies have attracted significant interest due to their potential to revolutionize the field. This shift has created promising op...
$4,950.00 -
06 Feb 2019  |  North America  |  Market Research
Implications on Utilisation of Diagnostic Imaging, 2017–2022
AI, Liquid Biopsy, and Innovation in PET, CT, and MRI Techniques have the Potential to Recast Imaging in Cardiology, Neurology and Oncology
This growth insight report presents an analysis of the technological and clinical disruptions that are set to impact the global medical imaging industry. The healthcare industry is undergoing rapid changes catalyzed by innovative technologies, and the impact on the imaging industry is likely to be quite significant. Though emerging technologies suc...
$3,000.00
Special Price $2,250.00 save 25 %
-
21 May 2026  |  Global  |  Market Research
Global Molecular Diagnostic Market—Opportunities and Growth Indicators
Unlocking Growth Through Early Disease Detection, Personalized Therapies, and Global Testing Expansion
The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...
$2,450.00 -
17 Jul 2017  |  North America  |  Market Research
US Oncology Diagnostics Market, Forecast to 2021
Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection
Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...
$4,950.00
Special Price $3,712.50 save 25 %
-
06 Jul 2017  |  Asia Pacific  |  Market Research
Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021
Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth
There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer thera...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Apr 2023  |  Global  |  Market Outlook
Global Next generation Diagnostics, Outlook 2023
Automation and Digitization Drive the Next Growth Phase Post-COVID-19
As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Aug 2025  |  Global  |  Technology Research
Second Skin Diagnostics: Innovations and Growth Opportunities, 2025–2029
Wearable diagnostic patches are revolutionizing non-invasive health monitoring, enabling real-time detection of biomarkers for personalized care
Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart...
$4,950.00 -
19 Feb 2025  |  Global  |  Market Research
Antimicrobial Resistance Diagnostics Market, Global, 2024–2030
The Shift to Whole-genome Sequencing and Multiplex Point-of-care Testing is Driving Transformational Growth Due to Improved Speed, Accuracy, and High Throughput
This Frost & Sullivan report examines the antimicrobial resistance (AMR) diagnostics market in human health. AMR, characterized by bacteria, viruses, and fungi that no longer respond to antimicrobial medications, is one of the top ten global public health threats. When pathogens develop drug resistance, medications become ineffective, leading to in...
$4,950.00
Special Price $4,455.00 save 10 %
-
14 Feb 2025  |  Global  |  Market Research
Proteomics Research Tools and Diagnostics Market, Global, 2024-2030
The Proteomics Industry is Experiencing Transformational Growth Due to Advancements in Proteomics Profiling and Biomarker Discovery
In the study, Frost & Sullivan examines the global proteomics research tools and diagnostics market, covering different product types, end users, and technologies. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones, largely driven by the research and pharmaceutical segments. The increasing...
$4,950.00
Special Price $4,455.00 save 10 %
-
21 Jul 2026  |  Global  |  Market Research
Point-of-Care Testing Market, Global, 2024–2031
The POCT Market is Experiencing Transformational Growth, Driven by Decentralized Molecular Diagnostics, Ultra-rapid Testing, and Connected Clinical Intelligence Ecosystems
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...
$2,450.00